Clinical Trials
14 trialsNCT00937456 2026-04-22
Open Versus Laparoscopically-assisted Esophagectomy for Cancer
University Hospital, Lille
Phase NA Completed
NCT02558504 2025-10-02
HARMONI
Hospices Civils de Lyon
Phase 4 Completed
NCT06256185 2024-02-13
Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase NA Completed
NCT01047111 2023-07-20
Esophagectomy: Sweet Versus Ivor-Lewis (ESVIL) (ECTOP-2001)
Fudan University
Phase NA Completed
NCT00318903 2023-05-25
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT02426879 2021-09-30
Node
UMC Utrecht
Phase NA Completed
NCT03529266 2021-08-24
PLACE020
Sun Yat-sen University
Phase 2 Completed
NCT01217060 2021-04-13
Trimodality Management of T1b Esophageal Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01544790 2020-03-26
ROBOT
UMC Utrecht
Phase 3 Completed
NCT00137852 2017-09-20
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02429622 2017-01-18
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
ChineseAMS
Phase 1/2 Completed
NCT01032967 2009-12-16
Surgery or Chemoradiation for Esophageal Cancer
Chinese University of Hong Kong
Phase 3 Completed
NCT00165061 2005-09-14
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
Chinese University of Hong Kong
Phase 3 Completed